1. /
  2. Our work /
  3. Projects /
  4. Identifying the barriers to hepatitis B clinical management: the perspectives of people with hepatitis B

Identifying the barriers to hepatitis B clinical management: the perspectives of people with hepatitis B

Past project

Clinical management, consisting of regular monitoring, and for a minority of people pharmaceutical treatment, reduces hepatitis B disease progression. Of all people with hepatitis B in Australia, only 13 per cent are clinically managed and of the 5 per cent that do receive pharmaceutical treatment, 20 per cent do not regularly take their medication.

Objective

A major gap in the public health response to hepatitis B is to identify the reasons for the reported ‘non-compliance’ of people with hepatitis B to the current model of care or identifying the elements of an effective clinical guideline and future model of care.

Timeline

2020–2021.

Partners

Funding partners

  • National Health and Medical Research Council (NHMRC)

Project contacts

Dr Jack Wallace

Dr Jack Wallace

Senior Research Officer
View profile

Project team

Associate Professor Jessica Howell

Associate Professor Jessica Howell

Co-head, Hepatitis B and Liver Cancer; Senior Research Fellow
View profile
Dr Jack Wallace

Dr Jack Wallace

Senior Research Officer
View profile
On this page